DEXCOM INC (DC4.DE) Stock Price, Quote, News and Overview
FRA:DC4 - Deutsche Boerse Ag - US2521311074 - Common Stock - Currency: EUR
DC4.DE Quote, Performance and Key Statistics
DEXCOM INC
FRA:DC4 (1/22/2025, 7:00:00 PM)
84.26
+1.87 (+2.27%)
The current stock price of DC4.DE is 84.26 EUR. In the past month the price increased by 9.24%. In the past year, price decreased by -27.85%.
DC4.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| IUI1.DE | INTUITIVE SURGICAL INC | 91.65 | 209.90B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 89.78 | 205.62B | ||
| ABL.DE | ABBOTT LABORATORIES | 26.41 | 198.32B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 43.14 | 143.70B | ||
| 2M6.DE | MEDTRONIC PLC | 16.84 | 108.61B | ||
| 1MDT.MI | MEDTRONIC PLC | 16.67 | 107.51B | ||
| BOX.DE | BECTON DICKINSON AND CO | 18.21 | 66.56B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 24.37 | 61.30B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 26.12 | 39.43B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 19.86 | 24.08B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 19.77 | 23.97B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 19.42 | 23.55B |
Related screens
About DC4.DE
Company Profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 9,600 full-time employees. The company went IPO on 2005-04-14. The firm enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The firm is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The firm is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.
Company Info
DEXCOM INC
6340 Sequence Dr
San Diego CALIFORNIA US
Employees: 9600
Company Website: https://www.dexcom.com/
Investor Relations: https://investors.dexcom.com
Phone: 18582000200
DC4.DE FAQ
What is the price of DC4.DE?
The current price of DC4.DE is 84.26 EUR.
What is the symbol for DEXCOM INC?
The exchange symbol of DEXCOM INC is DC4 and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is DC4.DE listed?
DC4.DE is listed on the Deutsche Boerse Ag exchange.
Is DC4.DE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for DC4.DE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of DC4.DE.
Does DC4.DE pay dividends?
DC4.DE does not pay a dividend.
When does DC4.DE report earnings?
DC4.DE will report earnings on 2025-02-13, after the market close.
What is the Price/Earnings (PE) ratio of DC4.DE?
The PE ratio for DC4.DE is 51.69. This is based on the reported non-GAAP earnings per share of 1.63 and the current share price of 84.26 EUR.
DC4.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to DC4.DE. When comparing the yearly performance of all stocks, DC4.DE is a bad performer in the overall market: 71.21% of all stocks are doing better.
DC4.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to DC4.DE. While DC4.DE has a great profitability rating, there are some minor concerns on its financial health.
DC4.DE Financial Highlights
Over the last trailing twelve months DC4.DE reported a non-GAAP Earnings per Share(EPS) of 1.63. The EPS increased by 25.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.22% | ||
| ROA | 10.71% | ||
| ROE | 34.4% | ||
| Debt/Equity | 1.26 |
DC4.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to DC4.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 15.31% and a revenue growth 11.48% for DC4.DE